Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1982 Jun;45(6):489–493. doi: 10.1136/jnnp.45.6.489

Brain transmitter precursors and metabolites in diabetic ketoacidosis.

G Curzon, B D Kantamaneni, N Callaghan, P A Sullivan
PMCID: PMC491424  PMID: 6181209

Abstract

Patients studied during recovery from an episode of ketoacidotic diabetes had raised blood glucose, plasma free fatty acid and plasma free tryptophan concentrations. Plasma total tryptophan was decreased. Well controlled diabetics showed normal values. The ketoacidotic patients had increased lumbar CSF tryptophan and 5-hydroxyindoleacetic acid concentrations. Plasma tyrosine and CSF tyrosine and homovanillic acid concentrations were normal in both diabetic groups. The results are discussed in relation to somewhat similar findings in uraemic and hepatic encephalopathy and to changes in rats with streptozotocin diabetes.

Full text

PDF
489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berger M., Zimmermann-Telschow H., Berchtold P., Drost H., Müller W. A., Gries F. A., Zimmermann H. Blood amine acid levels in patients with insulin excess (functioning insulinoma) and insulin deficiency (diabetic ketosis). Metabolism. 1978 Jul;27(7):793–799. doi: 10.1016/0026-0495(78)90214-7. [DOI] [PubMed] [Google Scholar]
  2. Bloxam D. L., Hutson P. H., Curzon G. A simple apparatus for ultrafiltration of small volumes: application to the measurement of free and albumin-bound tryptophan in plasma. Anal Biochem. 1977 Nov;83(1):130–142. doi: 10.1016/0003-2697(77)90518-8. [DOI] [PubMed] [Google Scholar]
  3. Boobis S. W. Alteration of plasma albumin in relation to decreased drug binding in uremia. Clin Pharmacol Ther. 1977 Aug;22(2):147–153. doi: 10.1002/cpt1977222147. [DOI] [PubMed] [Google Scholar]
  4. CAMPBELL J., BEST C. H. Physiologic aspects of ketosis. Metabolism. 1956 Mar;5(2):95–113. [PubMed] [Google Scholar]
  5. CAMPBELL J. Hyperlipidemia with ketoacidosis. Metabolism. 1962 Aug;11:762–780. [PubMed] [Google Scholar]
  6. Crandall E. A., Fernstrom J. D. Acute changes in brain tryptophan and serotonin after carbohydrate or protein ingestion by diabetic rats. Diabetes. 1980 Jun;29(6):460–466. doi: 10.2337/diab.29.6.460. [DOI] [PubMed] [Google Scholar]
  7. Curzon G., Fernando J. C. Drugs altering insulin secretion: effects on plasma and brain concentrations of aromatic amino acids and on brain 5-hydroxytryptamine turnover. Br J Pharmacol. 1977 Jul;60(3):401–408. doi: 10.1111/j.1476-5381.1977.tb07515.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Curzon G. Relationships between plasma, CSF and brain tryptophan. J Neural Transm Suppl. 1979;(15):81–92. doi: 10.1007/978-3-7091-2243-3_7. [DOI] [PubMed] [Google Scholar]
  9. Eccleston D., Ashcroft G. W., Crawford T. B. Effect of tryptophan administration on 5HIAA in cerebrospinal fluid in man. J Neurol Neurosurg Psychiatry. 1970 Apr;33(2):269–272. doi: 10.1136/jnnp.33.2.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fernando J. C., Knott P. J., Curzon G. The relevance of both plasma free tryptophan and insulin to rat brain tryptophan concentration. J Neurochem. 1976 Jul;27(1):343–345. doi: 10.1111/j.1471-4159.1976.tb01598.x. [DOI] [PubMed] [Google Scholar]
  11. Fischer J. E., Baldessarini R. J. Pathogenesis and therapy of hepatic coma. Prog Liver Dis. 1976;5:363–397. [PubMed] [Google Scholar]
  12. Fitzgerald M. G., O'Sullivan D. J., Malins J. M. Fatal Diabetic Ketosis. Br Med J. 1961 Jan 28;1(5221):247–250. doi: 10.1136/bmj.1.5221.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Friedman P. A., Kappelman A. H., Kaufman S. Partial purification and characterization of tryptophan hydroxylase from rabbit hindbrain. J Biol Chem. 1972 Jul 10;247(13):4165–4173. [PubMed] [Google Scholar]
  14. Gillman P. K., Bartlett J. R., Bridges P. K., Hunt A., Patel A. J., Kantamaneni B. D., Curzon G. Indolic substances in plasma, cerebrospinal fluid, and frontal cortex of human subjects infused with saline or tryptophan. J Neurochem. 1981 Aug;37(2):410–417. doi: 10.1111/j.1471-4159.1981.tb00470.x. [DOI] [PubMed] [Google Scholar]
  15. Greenwood M. H., Friedel J., Bond A. J., Curzon G., Lader M. H. The acute effects of intravenous infusion of L-tryptophan in normal subjects. Clin Pharmacol Ther. 1974 Sep;16(3):455–464. doi: 10.1002/cpt1974163part1455. [DOI] [PubMed] [Google Scholar]
  16. Greenwood M. H., Lader M. H., Kantameneni B. D., Curzon G. The acute effects of oral (--)-tryptophan in human subjects. Br J Clin Pharmacol. 1975 Apr;2(2):165–172. doi: 10.1111/j.1365-2125.1975.tb01572.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. James J. H., Escourrou J., Fischer J. E. Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science. 1978 Jun 23;200(4348):1395–1397. doi: 10.1126/science.663619. [DOI] [PubMed] [Google Scholar]
  18. Jellinger K., Riederer P. Brain monoamines in metabolic coma and stroke. Adv Neurol. 1978;20:535–546. [PubMed] [Google Scholar]
  19. Knell A. J., Davidson A. R., Williams R., Kantamaneni B. D., Curzon G. Dopamine and serotonin metabolism in hepatic encephalopathy. Br Med J. 1974 Mar 23;1(5907):549–551. doi: 10.1136/bmj.1.5907.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McMENAMY R. H., LUND C. C., ONCLEY J. L. Unbound amino acid concentrations in human blood plasmas. J Clin Invest. 1957 Dec;36(12):1672–1679. doi: 10.1172/JCI103568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. McMENAMY R. H., ONCLEY J. L. The specific binding of L-tryptophan to serum albumin. J Biol Chem. 1958 Dec;233(6):1436–1447. [PubMed] [Google Scholar]
  22. McMenamy R. H. Binding of indole analogues to human serum albumin. Effects of fatty acids. J Biol Chem. 1965 Nov;240(11):4235–4243. [PubMed] [Google Scholar]
  23. Sullivan P. A., Murnaghan D., Callaghan N., Kantamaneni B. D., Curzon G. Cerebral transmitter precursors and metabolites in advanced renal disease. J Neurol Neurosurg Psychiatry. 1978 Jul;41(7):581–588. doi: 10.1136/jnnp.41.7.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sullivan P. A., Murnaghan D., Callaghan N., Kantamaneni B. D., Curzon G. Effect of dialysis on plasma and CSF tryptophan and CSF 5-hydroxyindoleacetic acid in advanced renal disease. J Neurol Neurosurg Psychiatry. 1980 Aug;43(8):739–743. doi: 10.1136/jnnp.43.8.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tamarkin N. R., Goodwin F. K., Axelrod J. Rapid elevation of biogenic amine metabolites in human CSF following probenecid. Life Sci I. 1970 Dec 15;9(24):1397–1408. doi: 10.1016/0024-3205(70)90134-7. [DOI] [PubMed] [Google Scholar]
  26. Trulson M. E., MacKenzie R. G. Increased tryptophan hydroxylase activity may compensate for decreased brain tryptophan levels in streptozotocin-diabetic rats. J Pharmacol Exp Ther. 1980 Feb;212(2):269–273. [PubMed] [Google Scholar]
  27. Young E., Bradley R. F. Cerebral edema with irreversible coma in severe diabetic ketoacidosis. N Engl J Med. 1967 Mar 23;276(12):665–669. doi: 10.1056/NEJM196703232761204. [DOI] [PubMed] [Google Scholar]
  28. de Torrente A., Glazer G. B., Gulyassy P. Reduced in vitro binding of tryptophan by plasma in uremia. Kidney Int. 1974 Oct;6(4):222–229. doi: 10.1038/ki.1974.103. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES